Semaglutide vs semaglutide

Ozempic vs Wegovy

The most common question about these two is which one is 'better for weight loss.' The honest answer is that they are the same molecule: semaglutide. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management at a higher maintenance dose.

So the meaningful differences are not chemistry but approval, dosing, and insurance coverage, and, just as importantly, what happens at the off-ramp, which is identical because the drug is identical.

Educational only. This is educational, not medical advice. Everyone's body responds differently. Talk to your clinician before starting, stopping, changing, or tapering any medication, and work with your physician and a registered dietitian to personalize your approach.

At a glance

OzempicWegovy
Active drugSemaglutideSemaglutide
Approved forType 2 diabetesChronic weight management
Max maintenance dose2 mg weekly2.4 mg weekly
DosingOnce weekly injectionOnce weekly injection
Weight loss useOff-labelOn-label
CoverageOften via diabetes benefitWeight-management coverage is uneven

Are they the same drug?

Yes. Both Ozempic and Wegovy are semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. The molecule, the mechanism, and the side-effect profile are the same.

The main pharmacological difference is the top maintenance dose: Wegovy goes slightly higher (2.4 mg) because it is dosed specifically for weight management, while Ozempic tops out at 2 mg for diabetes.

Efficacy and side effects

At comparable doses, the weight effect is comparable because it is the same drug. In weight-management trials, semaglutide 2.4 mg produced average loss around 15 percent of body weight over 68 weeks.

Side effects (nausea, constipation, diarrhea, especially during dose escalation) are likewise the same, since they come from the same mechanism.

Which for whom

  • If you have type 2 diabetes, the diabetes brand may be covered through your diabetes benefit; that is a prescriber and insurance question.
  • If you are being treated for obesity, the weight-management brand is the on-label option.
  • Which brand you receive is a clinical and coverage decision for you and your prescriber, not something to choose yourself.
The off-ramp angle

Which holds weight better after you stop?

Because Ozempic and Wegovy are the same molecule, the off-ramp is identical. When you stop either, semaglutide clears, appetite hormones rebound, and weight tends to climb back, around 60 to 75 percent of the loss within a year in studies.

That means the maintenance plan does not depend on which brand you used. Protein, strength, sleep, habits, and clinician-guided options like tapering apply equally.

FAQ

Frequently asked questions

Is Wegovy stronger than Ozempic?

They are the same drug (semaglutide). Wegovy's top maintenance dose is slightly higher (2.4 vs 2 mg) because it is dosed for weight management, but the molecule and mechanism are identical.

Will switching between them change my weight regain?

No. Because they are the same molecule, the regain pattern after stopping is the same. What protects your loss is the maintenance plan, not the brand name.

Sources & further reading

Every claim on this page is drawn from peer-reviewed research, clinical trials, or recognized health authorities. Read the source before making any decision about your health.

  1. [1]Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight LossNIH/PMC
  2. [2]Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regressionNIH/PMC

The drugs

Related guides